Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Systolic Heart Failure - No Study Results Posted

Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Systolic Heart Failure (ESCAPE-SHF)

This study is currently recruiting participants.

Study NCT00923156 Information provided by Novartis

First Received: June 17, 2009 Last Updated: September 30, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	January 2011 (Final data collection date for primary outcome measure)